BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 33637103)

  • 21. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
    Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
    Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
    Shi Y; Zhang Q; Xie M; Feng Y; Ma S; Yi C; Wang Z; Li Y; Liu X; Liu H; Yang H; Yan Y; Zhang Y; Ren X; Luo H
    Oncol Rep; 2020 Dec; 44(6):2503-2516. PubMed ID: 33125127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hsa_circ_0006232 promotes laryngeal squamous cell cancer progression through FUS-mediated EZH2 stabilization.
    Wu T; Wang G; Zeng X; Sun Z; Li S; Wang W; Yu B
    Cell Cycle; 2021 Sep; 20(18):1799-1811. PubMed ID: 34437823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
    Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
    Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-induced transmembrane protein 1 (IFITM1) is essential for progression of laryngeal squamous cell carcinoma in an Osteopontin/NF-κB-dependent manner.
    Yin Y; Yang K; Li J; Da P; Zhang Z; Qiu X
    Cancer Biomark; 2020; 29(4):521-529. PubMed ID: 32865181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA N6-methyladenosine reader IGF2BP3 interacts with MYCN and facilitates neuroblastoma cell proliferation.
    Zhu K; Gao T; Wang Z; Zhang L; Tan K; Lv Z
    Cell Death Discov; 2023 May; 9(1):151. PubMed ID: 37156775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma.
    Du M; Peng Y; Li Y; Sun W; Zhu H; Wu J; Zong D; Wu L; He X
    Cell Death Discov; 2022 Feb; 8(1):53. PubMed ID: 35136045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioinformatic analyses of the role of m6A RNA methylation regulators in abdominal aortic aneurysm.
    Fu C; Feng L; Zhang J; Sun D
    Ann Transl Med; 2022 May; 10(10):547. PubMed ID: 35722410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of N6-methyladenosine RBM15 regulators in lung adenocarcinoma.
    Ma M; Wang W; Wang B; Yang Y; Huang Y; Zhao G; Ye L
    Cell Mol Biol (Noisy-le-grand); 2022 May; 68(1):130-139. PubMed ID: 35809319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Actin-like 6A enhances the proliferative and invasive capacities of laryngeal squamous cell carcinoma by potentiating the activation of YAP signaling.
    Dang Y; Zhang L; Wang X
    J Bioenerg Biomembr; 2020 Dec; 52(6):453-463. PubMed ID: 33067739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA LINC01638 contributes to laryngeal squamous cell cancer progression by modulating miR-523-5p/BATF3 axis.
    Zhang H; Zhao X; Wang M; Ji W
    Aging (Albany NY); 2021 Mar; 13(6):8611-8619. PubMed ID: 33714208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. M6A reader YTHDF1 promotes malignant progression of laryngeal squamous carcinoma through activating the EMT pathway by EIF4A3.
    Guo H; Han Q; Guan X; Li Z; Wang Y; He L; Guo Y; Zhao L; Xue X; Liu H; Zhang C
    Cell Signal; 2024 Feb; 114():111002. PubMed ID: 38048860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
    Wei K; Gao Y; Wang B; Qu YX
    Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of long non-coding RNA RP11-297P16.3 inhibits the migration and invasion of laryngeal squamous carcinoma cells.
    Wu H; Wang W; Zhu J
    Clin Transl Oncol; 2021 Oct; 23(10):2057-2065. PubMed ID: 33893613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.
    Wang B; Zhao L; Chi W; Cao H; Cui W; Meng W
    Epigenetics Chromatin; 2019 Jun; 12(1):35. PubMed ID: 31196171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RBM15-Mediated m6A Modification of K17 Affects Keratinocytes Response to IL-17A Stimulation in Psoriasis.
    Fu M; Zhou B; Shi N; Dong R; Chen Y
    Ann Clin Lab Sci; 2023 Jul; 53(4):529-538. PubMed ID: 37625827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IGF2BP3 regulates the expression of RRM2 and promotes the progression of rheumatoid arthritis via RRM2/Akt/MMP-9 pathway.
    Ban Z; Li Z; Xing S; Ye Y
    PLoS One; 2024; 19(5):e0303593. PubMed ID: 38820515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA lnc-H2AFV-1 promotes cell growth by regulating aberrant m6A RNA modification in head and neck squamous cell carcinoma.
    Chen X; Liu Y; Sun D; Sun R; Wang X; Li M; Song N; Ying J; Guo T; Jiang Y
    Cancer Sci; 2022 Jun; 113(6):2071-2084. PubMed ID: 35403343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.